SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
70 hedge funds and large institutions have $141M invested in Sierra Oncology, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
-3
Holders Change %
-4.11%
% of All Funds
1.6%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
14
Increased
14
Reduced
18
Closed
16
Calls
–
Puts
$30K
Net Calls
-$30K
Net Calls Change
-$9K
Top Buyers
| 1 |
BC
Broadfin Capital
New York
|
+$6.24M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$3.8M |
| 3 |
Morgan Stanley
New York
|
+$1.75M |
| 4 |
Alkeon Capital Management
New York
|
+$1.13M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$851K |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$2.77M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.46M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
-$2.17M |
| 4 |
PA
Perceptive Advisors
New York
|
-$1.48M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.18M |
